Amyris
ProfileJobs

Amyris

Suggest Edit
    • Energy & UtilitiesManufacturing & Industrialchemicalscleantechfuelsrenewables
    Amyris is an integrated renewable products company providing sustainable alternatives to petroleum-sourced products and rare materials. The Company uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules, flexible building blocks which can be used in a wide range of products. Amyris is commercializing these products both as renewable ingredients in cosmetics, flavors, fragrances, polymers, lubricants and consumer products and also as renewable diesel and jet fuels.
    Revenue(FY, 2017)
    $143.4 M
    Market capitalization(2018-04-20)
    $204.5 M
    Type
    Public
    HQ
    Emeryville, US
    Founded
    2003
    Size (employees)
    440 (est)
    Website
    amyris.com
    Amyris was founded in 2003 and is headquartered in Emeryville, US
    Report incorrect company information

    Key People/Management at Amyris

    Kathleen Valiasek

    Kathleen Valiasek

    Chief Financial Officer
    Eduardo Alvarez

    Eduardo Alvarez

    Chief Operating Officer
    Joel Cherry

    Joel Cherry

    President, Research & Development
    Cynthia Bryant

    Cynthia Bryant

    Senior Vice President Corporate Development & Collaborations
    Caroline Hadfield

    Caroline Hadfield

    Senior Vice President, Personal Care
    Jim Iacoponi

    Jim Iacoponi

    Senior Vice President, Business Operations & Optimization
    Show more

    Amyris Office Locations

    Amyris has offices in Techno Park and Emeryville
    Emeryville, US (HQ)
    100 5885 Hollis St
    Techno Park, BR
    Rua John Dalton, 301 - Bloco B - Edificio 3
    Show all (2)
    Report incorrect company information

    Amyris Financials and Metrics

    Amyris Financials

    Amyris's revenue was reported to be $143.45 m in FY, 2017
    USD

    Revenue (FY, 2017)

    		143.4 m

    Gross profit (FY, 2017)

    		80.7 m

    Gross profit margin (FY, 2017), %

    		56.3%

    Net income (FY, 2017)

    		(72.3 m)

    EBIT (FY, 2017)

    		(39.5 m)

    Market capitalization (20-Apr-2018)

    		204.5 m

    Cash (31-Dec-2017)

    		57.1 m

    EV

    		246.2 m
    Amyris's current market capitalization is $204.5 m.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		41.1 m43.3 m34.2 m67.2 m143.4 m

    Revenue growth, %

    		5%(21%)97%

    Cost of goods sold

    		38.3 m33.2 m37.4 m56.7 m62.7 m

    Gross profit

    		2.9 m10.1 m(3.2 m)10.5 m80.7 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Revenue

    		7 m6 m9.3 m16.3 m7.9 m7.8 m8.6 m8.8 m9.6 m26.5 m13 m25.7 m24.2 m

    Cost of goods sold

    		8.3 m6.2 m7.5 m10.1 m6.6 m11 m8.5 m11.2 m7.9 m14.9 m12.8 m17.3 m17.6 m

    Gross profit

    		(1.3 m)(195 k)1.8 m6.2 m1.2 m(3.1 m)136 k(2.4 m)1.7 m11.7 m212 k8.4 m6.6 m

    Gross profit Margin, %

    		(19%)(3%)19%38%16%(40%)2%(27%)18%44%2%33%27%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		6.9 m42 m12 m27.2 m57.1 m

    Accounts Receivable

    		62.8 k33.6 m

    Inventories

    		9.5 m6.5 m5.9 m6.2 m5.4 m

    Current Assets

    		36.9 m73.6 m35.7 m59.1 m104.6 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

    Cash

    		5.8 m47.8 m88.8 m67.2 m43.8 m10.9 m10.9 m7.8 m822 k582 k1.3 m5.1 m15.9 m

    Accounts Receivable

    		24.9 m

    Inventories

    		7.9 m11.1 m14.8 m16.7 m11.4 m11.1 m11.1 m7.6 m10 m7.9 m7.1 m5.7 m6.4 m

    Current Assets

    		25.3 m73.8 m116.8 m102.9 m69.3 m36.1 m34.6 m27.7 m21.5 m21.1 m24.1 m41 m62.3 m
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		(234.9 m)2.2 m(218.1 m)(97.3 m)(72.3 m)

    Depreciation and Amortization

    		16.6 m15 m12.9 m11.4 m11.4 m

    Inventories

    		(3.1 m)

    Accounts Payable

    		(2.6 m)(3.2 m)4.4 m6.4 m5.9 m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

    Net Income

    		(24.2 m)16.4 m(35.5 m)(36.7 m)(52.3 m)(99.4 m)(176.1 m)(15.3 m)(28.9 m)(48.6 m)(37.4 m)

    Depreciation and Amortization

    		6.8 m9.9 m2.9 m5.7 m8.6 m2.7 m

    Accounts Payable

    		8.5 m5.8 m4.6 m3 m7.3 m(810 k)1.2 m4.3 m450 k

    Cash From Operating Activities

    		(32.8 m)(52.2 m)(23.7 m)(39 m)(45.4 m)(25.4 m)
    show all
    USDY, 2017

    EV/EBIT

    		-6.2 x

    EV/CFO

    		-2.4 x

    Revenue/Employee

    		331.5 k

    Financial Leverage

    		-0.8 x
    Show all financial metrics
    Report incorrect company information

    Competitors

    Ind-Barath Power Infra
    Energy & Utilities - Private
    Petrotec
    Energy & Utilities - Subsidiary
    LanzaTech
    Energy & Utilities - Private
    Gevo
    Energy & Utilities - Public
    Compare competitors

    Amyris News and Updates

    November 22, 2017

    Synthetic Biology 2017 Global Key Players –Amyris, Inc. (U.S.), DowDuPont (U.S.), GenScript USA Inc. (U.S.), Intrexon Corporation (U.S.), Integrated DNA Technologies (IDT) (U.S.) Market Analysis And Forecast To 2022

    Wiseguyreports.Com Adds “Synthetic Biology-Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2022” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday
    Report incorrect company information
    Download PDF